Voya Financial Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History

Voya Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $186,939 - $217,902	-903 Closed	0 $0
Q4 2020 Mar 05, 2021	SELL	$207.01 - $276.09 $41,402 - $55,217	-200 Reduced 18.13%	903 $210,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $43,716 - $51,830	171 Added 18.35%	1,103 $298,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $210,147 - $275,685	932 New	932 $266,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.